-transparent.png){kind=logo}
The mechanism of action of cyclopropamitosenes, novel bioreductive anticancer agents, has been investigated using a unique combination of chemical and biochemical techniques. The compounds 4 function as reductively activated alkylating agents under chemical reducing conditions, and the biochemical experiments establish that the methoxy- and aziridinyl-derivatives 4a and 4b behave differently upon bioreduction.
Related Publications
C J Moody, and
N O'Sullivan, and
I J Stratford, and
M A Stephens, and
P Workman, and
S M Bailey, and
A Lewis
May 1997,
Farmaco (Societa chimica italiana : 1989),
C J Moody, and
N O'Sullivan, and
I J Stratford, and
M A Stephens, and
P Workman, and
S M Bailey, and
A Lewis
December 1974,
Cancer chemotherapy reports. Part 2,
C J Moody, and
N O'Sullivan, and
I J Stratford, and
M A Stephens, and
P Workman, and
S M Bailey, and
A Lewis
August 1999,
Cancer biotherapy & radiopharmaceuticals,
C J Moody, and
N O'Sullivan, and
I J Stratford, and
M A Stephens, and
P Workman, and
S M Bailey, and
A Lewis
November 1995,
Mutation research,
C J Moody, and
N O'Sullivan, and
I J Stratford, and
M A Stephens, and
P Workman, and
S M Bailey, and
A Lewis
February 2013,
Science (New York, N.Y.),
C J Moody, and
N O'Sullivan, and
I J Stratford, and
M A Stephens, and
P Workman, and
S M Bailey, and
A Lewis
September 1998,
Anti-cancer drug design,
C J Moody, and
N O'Sullivan, and
I J Stratford, and
M A Stephens, and
P Workman, and
S M Bailey, and
A Lewis
January 1954,
Advances in enzymology and related subjects of biochemistry,
C J Moody, and
N O'Sullivan, and
I J Stratford, and
M A Stephens, and
P Workman, and
S M Bailey, and
A Lewis
April 2020,
Future medicinal chemistry,
C J Moody, and
N O'Sullivan, and
I J Stratford, and
M A Stephens, and
P Workman, and
S M Bailey, and
A Lewis
March 1988,
Anti-cancer drug design,
C J Moody, and
N O'Sullivan, and
I J Stratford, and
M A Stephens, and
P Workman, and
S M Bailey, and
A Lewis
April 1999,
Cancer research,
